Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS_1158, Paris, France.
Department of Respiratory and Critical Care Medicine, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), AP-HP, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.
J Neurol. 2017 Nov;264(11):2303-2312. doi: 10.1007/s00415-017-8624-7. Epub 2017 Oct 9.
The purpose of this study is to describe the reasons for ICU admission and to evaluate the outcome and prognostic factors of patients with primary malignant brain tumors (PMBT) admitted to the intensive care unit (ICU). This is a retrospective observational cohort study of 196 PMBT patients admitted to two ICUs over a 19-year period. Acute respiratory failure was the main reason for ICU admission (45%) followed by seizures (25%) and non-epileptic coma (14%). Seizures were more common in patients with glial lesions (84 vs. 67%), whereas patients with primary brain lymphoma were more frequently admitted for shock (42 vs. 18%). Overall ICU and 90-day mortality rates were 23 and 50%, respectively. Admission for seizures was independently associated with lower ICU mortality [odds ratio (OR) 0.06], whereas the need for mechanical ventilation (OR 6.85), cancer progression (OR 7.84), respiratory rate (OR 1.11) and Glasgow coma scale (OR 0.85) were associated with higher ICU mortality. Among the 95 patients who received invasive mechanical ventilation, ICU mortality was 37% (n = 35). For these patients, admission for seizures was associated with lower ICU mortality (OR 0.050) whereas cancer progression (OR 7.49) and respiratory rate (OR 1.08) were associated with higher ICU mortality. The prognosis of PMBT patients admitted to the ICU appears relatively favorable compared to that of hematologic malignancies or solid tumors, especially when the patient is admitted for seizures. The presence of a PMBT, therefore, does not appear to be sufficient for refusal of ICU admission. Predictive factors of mortality may help clinicians make optimal triage decisions.
本研究旨在描述入住 ICU 的原因,并评估原发性脑恶性肿瘤(PMBT)患者入住 ICU 的结局和预后因素。这是一项回顾性观察性队列研究,纳入了 19 年间入住 2 个 ICU 的 196 例 PMBT 患者。急性呼吸衰竭是入住 ICU 的主要原因(45%),其次是癫痫发作(25%)和非癫痫性昏迷(14%)。癫痫发作在胶质病变患者中更为常见(84%比 67%),而原发性脑淋巴瘤患者更常因休克而入住(42%比 18%)。总体 ICU 死亡率和 90 天死亡率分别为 23%和 50%。癫痫发作是 ICU 死亡率降低的独立预测因素[比值比(OR)0.06],而需要机械通气(OR 6.85)、癌症进展(OR 7.84)、呼吸频率(OR 1.11)和格拉斯哥昏迷评分(OR 0.85)与 ICU 死亡率升高相关。在接受有创机械通气的 95 例患者中,ICU 死亡率为 37%(n=35)。对于这些患者,癫痫发作是 ICU 死亡率降低的独立预测因素(OR 0.050),而癌症进展(OR 7.49)和呼吸频率(OR 1.08)与 ICU 死亡率升高相关。与血液系统恶性肿瘤或实体肿瘤相比,PMBT 患者入住 ICU 的预后似乎相对较好,尤其是当患者因癫痫发作而入住时。因此,PMBT 的存在似乎不足以拒绝 ICU 收治。死亡率的预测因素可能有助于临床医生做出最佳分诊决策。